Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Clinical trial NCT05919238 · RECRUITING
Trial details
- NCT number
- NCT05919238
- Sponsor
- Impact Biotech Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2026-08-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.